Try our Advanced Search for more refined results

Public Policy

Public Policy Law360 provides breaking news and analysis across the public policy spectrum. Coverage includes state, federal, and international legislation, agency rulemaking, advocacy initiatives, and government relations, as well as legal challenges to laws and regulations.



Sign up for a 7-day FREE trial today!



Latest News in Public Policy

  • April 14, 2026

    4th Circ. Revives Pharma Bid To Block Maryland's 340B Law

    A split Fourth Circuit panel on Tuesday tossed a Maryland district court's order denying a preliminary injunction to pharmaceutical manufacturers that have challenged a state law addressing drug delivery in the federal 340B discount program, pointing to its recent ruling that West Virginia's similar statute is likely preempted.

  • April 14, 2026

    Westlake Inks $67M Antitrust Deal With PVC Pipe Buyers

    Purchasers of polyvinyl chloride pipe urged an Illinois federal judge Tuesday to sign off on a proposed $67 million deal with Westlake Corp. that would put to rest allegations it and other PVC pipe producers conspired to fix prices, according to a motion filed in Illinois federal court.

  • April 14, 2026

    26 State AGs Urge FTC To Ban Deceptive Rental Fee Tactics

    A bipartisan coalition of 26 state attorneys general led by New Jersey and Colorado called on the Federal Trade Commission on Monday to adopt a requirement that residential landlords clearly disclose all costs to tenants up front, responding to the agency's notice last month of potential rulemaking to combat hidden rental fees.

  • April 14, 2026

    States Denied Time For Talks To Settle Drug Price-Fixing Suit

    A Connecticut federal judge Tuesday denied a request by dozens of U.S. states to freeze their antitrust case against generic-drug manufacturers, a pause the states argued would allow the parties to focus on settlement talks rather than pending discovery and motion deadlines.

  • April 14, 2026

    Justices Told That Eli Lilly's FCA Qui Tam Challenge Too Late

    A whistleblower who secured a $183 million trial win against Eli Lilly urged the U.S. Supreme Court on Tuesday to reject its constitutional challenge over his ability to sue for the federal government, arguing the drugmaker's arguments came too late.

See more Public Policy news

Public Policy

Areas of Coverage

  • POLICY & REGULATION
  • Bills in Congress and state legislatures
  • Congressional hearings and investigations
  • Developments in congressional leadership
  • Agency rulemaking and implementation
  • Watchdog investigations and reports
  • Federal and state elections
  • Lobbying rules and activity
  • Government spending surveys
  • AGENCIES
  • Congressional Budget Office
  • U.S. Government Accountability Office
  • White House Office of Management and Budget
  • Federal, state, and municipal government agencies
  • Intergovernmental agencies
  • LITIGATION
  • Lawsuits over the scope and application of laws and regulations
  • PROFILES
  • Personnel changes and appointments at regulatory agencies
  • Lateral hires in government affairs, public policy, and lobbying practices
  • Law firm hires in connection with advocacy initiatives
  • Profiles of public policy and government relations practices

Readership

  • Public policy and government relations lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Legislators and staff
  • Policymakers at federal and state agencies
  • Lobbyists, industry groups, and trade associations
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals